Third-line antiepileptic therapy and outcome in status epilepticus: The impact of vasopressor use and prolonged mechanical ventilation

Critical Care Medicine

Volumn 40, Issue 9, 2012, Pages 2677-2684

  Kowalski, Robert G ^a   Ziai, Wendy C ^a   Rees, Richard N ^a   Werner, J Kent ^b   Kim, Grace ^a   Goodwin, Haley ^c   Geocadin, Romergryko G ^a,b  

^a Helen Diller Family Comprehensive Cancer Center   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

anesthetic; antiepileptic drugs; hypotension; refractory seizures; status epilepticus; third line; vasopressors; ventilation

Indexed keywords

ADRENALIN; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; DOPAMINE; ETIRACETAM; FOSPHENYTOIN SODIUM; HYPERTENSIVE AGENT; LORAZEPAM; MIDAZOLAM; NORADRENALIN; PENTOBARBITAL; PHENOBARBITAL; PHENYLEPHRINE; PHENYTOIN; PROPOFOL; VALPROIC ACID;

ADULT; ADVERSE OUTCOME; AGE; AGED; ANTICONVULSANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONVULSION; DEATH; DRUG SAFETY; EPILEPTIC STATE; FEMALE; GLASGOW OUTCOME SCALE; HEMODYNAMICS; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEDATION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ANTICONVULSANTS; APACHE; CONFIDENCE INTERVALS; CRITICAL ILLNESS; EMERGENCY SERVICE, HOSPITAL; FEMALE; GLASGOW COMA SCALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PENTOBARBITAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATUS EPILEPTICUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 84865469057     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182591ff1     Document Type: Article

References (41)

1. Lowenstein DH: The management of refractory status epilepticus: An update. Epilepsia 2006; 47(Suppl 1):35-40
2. Cereda C, Berger MM, Rossetti AO: Bowel ischemia: A rare complication of thiopental treatment for status epilepticus. Neurocrit Care 2009; 10:355-358
3. Working Group on Status Epilepticus: Treatment of convulsive status epilepticus. Recommendations of the epilepsy foundation of America's working group on status epilepticus. JAMA 1993; 270:854-859
4. Treiman DM, Meyers PD, Walton NY, et al: Veterans Affairs Status Epilepticus Cooperative Study Group: A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998; 339:792-798
5. Leppik IE, Derivan AT, Homan RW, et al: Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983; 249:1452-1454
6. Alldredge BK, Gelb AM, Isaacs SM, et al: A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345:631-637
7. Rossetti AO, Milligan TA, Vulliémoz S, et al: A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011; 14:4-10
8. Manno EM: New management strategies in the treatment of status epilepticus. Mayo Clin Proc 2003; 78:508-518
9. Cock HR; ESETT Group: Established status epilepticus treatment trial (ESETT). Epilepsia 2011; 52(Suppl 8):50-52
10. Bialer M: Pharmacodynamic and pharmacokinetic characteristics of intravenous drugs in status epilepticus. Epilepsia 2009; 50(Suppl 12):44-48
11. Rüegg S, Naegelin Y, Hardmeier M, et al: Intravenous levetiracetam: Treatment experience with the first 50 critically ill patients. Epilepsy Behav 2008; 12:477-480
12. Mayer SA, Claassen J, Lokin J, et al: Refractory status epilepticus: Frequency, risk factors, and impact on outcome. Arch Neurol 2002; 59:205-210
13. Holtkamp M: Treatment strategies for refractory status epilepticus. Curr Opin Crit Care 2011; 17:94-100
14. Meierkord H, Boon P, Engelsen B, et al: European Federation of Neurological Societies: EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010; 17:348-355
15. Lowenstein DH, Alldredge BK: Status epilepticus. N Engl J Med 1998; 338:970-976
16. Lowenstein DH, Bleck T, Macdonald RL: It's time to revise the definition of status epilepticus. Epilepsia 1999; 40:120-122
17. Parviainen I, Kälviäinen R, Ruokonen E: Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: Pros and cons. Neurol Res 2007; 29:667-671
18. Iyer VN, Hoel R, Rabinstein AA: Propofol infusion syndrome in patients with refractory status epilepticus: An 11-year clinical experience. Crit Care Med 2009; 37:3024-3030
19. Lawn ND, Wijdicks EF: Progress in clinical neurosciences: Status epilepticus: A critical review of management options. Can J Neurol Sci 2002; 29:206-215
20. Drislane FW, Blum AS, Lopez MR, et al: Duration of refractory status epilepticus and outcome: Loss of prognostic utility after several hours. Epilepsia 2009; 50:1566-1571
21. Trinka E, Shorvon S: The proceedings of the Innsbruck Colloquium on Status Epilepticus. Epilepsia 2009; 50(Suppl 12):1-2
22. Novy J, Logroscino G, Rossetti AO: Refractory status epilepticus: A prospective observational study. Epilepsia 2010; 51:251-256
23. Logroscino G, Hesdorffer DC, Cascino G, et al: Short-term mortality after a first episode of status epilepticus. Epilepsia 1997; 38:1344-1349
24. Ducrocq SC, Meyer PG, Orliaguet GA, et al: Epidemiology and early predictive factors of mortality and outcome in children with traumatic severe brain injury: Experience of a French pediatric trauma center. Pediatr Crit Care Med 2006; 7:461-467
25. Toutant SM, Klauber MR, Marshall LF, et al: Absent or compressed basal cisterns on first CT scan: Ominous predictors of outcome in severe head injury. J Neurosurg 1984; 61:691-694
26. Chamoun RB, Robertson CS, Gopinath SP: Outcome in patients with blunt head trauma and a Glasgow Coma Scale score of 3 at presentation. J Neurosurg 2009; 111:683-687
27. Rossetti AO, Hurwitz S, Logroscino G, et al: Prognosis of status epilepticus: Role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatr 2006; 77:611-615
28. Power KN, Flaatten H, Gilhus NE, et al: Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. Epilepsy Res 2011; 94:53-60
29. Varelas PN, Mirski MA: Status epilepticus. Curr Neurol Neurosci Rep 2009; 9:469-476
30. Koubeissi M, Alshekhlee A: In-hospital mortality of generalized convulsive status epilepticus: A large US sample. Neurology 2007; 69:886-893
31. Sperry JL, Minei JP, Frankel HL, et al: Early use of vasopressors after injury: Caution before constriction. J Trauma 2008; 64:9-14
32. Guérin JP, Levraut J, Samat-Long C, et al: Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics, oxygen exchange, and energy balance in vasoplegic septic patients. Shock 2005; 23:18-24
33. Herget-Rosenthal S, Saner F, Chawla LS: Approach to hemodynamic shock and vasopressors. Clin J Am Soc Nephrol 2008; 3:546-553
34. Tsapenko MV, Tsapenko AV, Comfere TB, et al: Arterial pulmonary hypertension in noncardiac intensive care unit. Vasc Health Risk Manag 2008; 4:1043-1060
35. Muzevich KM, Voils SA: Role of vasopressor administration in patients with acute neurologic injury. Neurocrit Care 2009; 11:112-119
36. Claassen J, Hirsch LJ, Emerson RG, et al: Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review. Epilepsia 2002; 43:146-153
37. Rossetti AO, Logroscino G, Bromfield EB: Refractory status epilepticus: Effect of treatment aggressiveness on prognosis. Arch Neurol 2005; 62:1698-1702
38. Legriel S, Azoulay E, Resche-Rigon M, et al: Functional outcome after convulsive status epilepticus. Crit Care Med 2010; 38:2295-2303
39. Krishnamurthy KB, Drislane FW: Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996; 37:863-867
40. Holtkamp M, Othman J, Buchheim K, et al: Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatr 2005; 76:534-539
41. Mirski MA, Williams MA, Hanley DF: Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med 1995; 23:400-404